Roth Capital Partners will host its 5th Annual Healthcare Opportunities Conference on Sept. 29, 2026, at the Metropolitan Club in New York City. The invitation-only event will bring together C-suite executives from more than 30 public healthcare companies and leading institutional investors for a day of one-on-one and small-group meetings.
The conference will feature companies representing biotechnology, life science tools and diagnostics, and medical technology. Discussions will cover critical topics including neuroscience, drug pricing and coverage, regulatory uncertainty, capital constraints in biotechnology, and minimal residual disease (MRD) monitoring in solid tumors. The event will be hosted by ROTH senior healthcare research analysts Jonathan Aschoff, Ph.D., Max Masucci, Boobalan Pachaiyappan, Ph.D., and Adam Walsh, MD.
This conference matters because it provides a rare opportunity for institutional investors to engage directly with top healthcare executives at a time when the sector faces significant headwinds. Regulatory and pricing pressures, along with capital constraints, are reshaping the biotechnology landscape, and events like this can help investors identify opportunities and risks. Since 2010, ROTH has been involved in more than 600 transactions for healthcare clients representing over $25 billion in total transaction value, underscoring its deep expertise in the sector.
For those interested in attending or learning more about ROTH’s events, the full calendar is available at https://ibn.fm/vDTjP. ROTH is a relationship-driven investment bank focused on serving growth companies and their investors. Its full-service platform includes capital raising, equity research, macroeconomics, sales and trading, derivatives strategies, M&A advisory, and corporate access. Headquartered in Newport Beach, California, ROTH is a privately held, employee-owned firm with offices across the U.S. More information is available at www.roth.com.
The conference is being publicized through InvestorWire, a specialized communications platform for wire-grade press release syndication. InvestorWire is part of the Dynamic Brand Portfolio at IBN, which offers access to a vast network of wire solutions, article and editorial syndication to 5,000+ outlets, and social media distribution to millions of followers. These services help companies reach a wide audience of investors, journalists, and the public. For more details, visit InvestorWire.
As the healthcare industry continues to evolve, conferences like this play a vital role in facilitating dialogue between companies and investors, potentially influencing investment decisions and shaping the future of healthcare innovation. The event’s focus on pressing issues such as drug pricing and regulatory uncertainty highlights the challenges and opportunities that lie ahead for the sector.
